Why the study?
Do subject-specific recursive linear time series models improve the prediction and prevention of hypoglycemia in patients with Type 1 diabetes?
Do subject-specific recursive linear time series models improve the prediction and prevention of hypoglycemia in patients with Type 1 diabetes?
Subject-specific recursive linear time series models can effectively predict future glucose concentrations and provide early alarms to prevent hypoglycemia in Type 1 diabetes.
This is the authors' abstract. We don't add key points for this paper.
Hypoglycemia is a major challenge of artificial pancreas systems and a source of concern for potential users and parents of young children with Type 1 diabetes (T1D). Early alarms to warn the potential of hypoglycemia are essential and should provide enough time to take action to avoid hypoglycemia. Many alarm systems proposed in the literature are based on interpretation of recent trends in glucose values. In the present study, subject-specific recursive linear time series models are introduced as a better alternative to capture glucose variations and predict future blood glucose concentrations. These models are then used in hypoglycemia early alarm systems that notify patients to take action to prevent hypoglycemia before it happens. The models developed and the hypoglycemia alarm system are tested retrospectively using T1D subject data. A Savitzky-Golay filter and a Kalman filter are used to reduce noise in patient data. The hypoglycemia alarm algorithm is developed by using predictions of future glucose concentrations from recursive models. The modeling algorithm enables the dynamic adaptation of models to inter-/intra-subject variation and glycemic disturbances and provides satisfactory glucose concentration prediction with relatively small error. The alarm systems demonstrate good performance in prediction of hypoglycemia and ultimately in prevention of its occurrence.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for hypoglycemia alarms in T1D; leaves open larger randomized validation before clinical use.
No takes yet. Share an insight, caveat, or question.
Turksoy et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: